Blood test clues could predict ovarian cancer survival
NCT ID NCT03862677
First seen Feb 23, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study is collecting blood samples from 300 people with ovarian cancer to find immune markers that might predict how the disease will progress. Researchers will look at certain immune cells to see if they are linked to survival. No new treatment is given; the goal is to learn more about the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Leiden University Medical Center
RECRUITINGLeiden, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.